rts logo

Fennec Pharmaceuticals Inc (FENC) – Don’t Be So Quick to Call it Dead

Fennec Pharmaceuticals Inc (NASDAQ: FENC) is -37.79% lower on its value in year-to-date trading and has touched a low of $6.30 and a high of $11.92 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FENC stock was last observed hovering at around $7.34 in the last trading session, with the day’s loss setting it -0.36%.

Currently trading at $6.98, the stock is -24.39% and -30.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.78 million and changing -4.90% at the moment leaves the stock -22.36% off its SMA200. FENC registered -8.64% loss for a year compared to 6-month gain of -11.31%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -31.97% loss in the last 1 month and extending the period to 3 months gives it a -24.13%, and is -24.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.96% over the week and 6.38% over the month.

Fennec Pharmaceuticals Inc (FENC) has around 29 employees, a market worth around $189.16M and $44.95M in sales. Current P/E ratio is 188.65 and Fwd P/E is 12.17. Profit margin for the company is 6.33%. Distance from 52-week low is 10.79% and -41.44% from its 52-week high. The company has generated returns on investments over the last 12 months (8.69%).

The EPS is expected to grow by 185.28% this year

The shares outstanding are 27.03M, and float is at 23.14M with Short Float at 7.84%.

Fennec Pharmaceuticals Inc (FENC) Insider Activity

The most recent transaction is an insider sale by Raykov Rosty, the company’s CHIEF EXECUTIVE OFFICER. SEC filings show that Raykov Rosty sold 2,431 shares of the company’s common stock on May 01 ’24 at a price of $9.11 per share for a total of $22152.0. Following the sale, the insider now owns 0.19 million shares.

Fennec Pharmaceuticals Inc disclosed in a document filed with the SEC on Apr 22 ’24 that Haigh Adrian (CHIEF OPERATING OFFICER) sold a total of 22,223 shares of the company’s common stock. The trade occurred on Apr 22 ’24 and was made at $9.32 per share for $0.21 million. Following the transaction, the insider now directly holds 0.0 shares of the FENC stock.

Still, SEC filings show that on Apr 19 ’24, Haigh Adrian (CHIEF OPERATING OFFICER) disposed off 22,222 shares at an average price of $9.34 for $0.21 million. The insider now directly holds 0 shares of Fennec Pharmaceuticals Inc (FENC).

Related Posts